ES2184285T3 - Compuestos farmaceuticos que contienen diclorhidrato de cinconina. - Google Patents

Compuestos farmaceuticos que contienen diclorhidrato de cinconina.

Info

Publication number
ES2184285T3
ES2184285T3 ES98929515T ES98929515T ES2184285T3 ES 2184285 T3 ES2184285 T3 ES 2184285T3 ES 98929515 T ES98929515 T ES 98929515T ES 98929515 T ES98929515 T ES 98929515T ES 2184285 T3 ES2184285 T3 ES 2184285T3
Authority
ES
Spain
Prior art keywords
cinconine
dichlorhydrate
compounds containing
pharmaceutical compounds
cinchonine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES98929515T
Other languages
English (en)
Inventor
Philippe Genne
Houssam Ibrahim
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Debiopharm SA
Original Assignee
Debiopharm SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Debiopharm SA filed Critical Debiopharm SA
Application granted granted Critical
Publication of ES2184285T3 publication Critical patent/ES2184285T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/49—Cinchonan derivatives, e.g. quinine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Cardiology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

La invención se refiere a composiciones farmacéuticas que contienen diclorhidrato de chinchonina como principio activo, que presenta una pureza al menos igual a 95%. La invención se refiere también a un procedimiento de preparación del diclorhidrato de chinchonina a partir de la chinchonina así como la utilización de las composiciones farmacéuticas que contienen diclorhidrato de chinchonina para el tratamiento del fenómeno de la resistencia multidroga.
ES98929515T 1997-06-11 1998-06-08 Compuestos farmaceuticos que contienen diclorhidrato de cinconina. Expired - Lifetime ES2184285T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9707234A FR2764509A1 (fr) 1997-06-11 1997-06-11 Compositions pharmaceutiques contenant du dichlorhydrate de cinchonine

Publications (1)

Publication Number Publication Date
ES2184285T3 true ES2184285T3 (es) 2003-04-01

Family

ID=9507852

Family Applications (1)

Application Number Title Priority Date Filing Date
ES98929515T Expired - Lifetime ES2184285T3 (es) 1997-06-11 1998-06-08 Compuestos farmaceuticos que contienen diclorhidrato de cinconina.

Country Status (14)

Country Link
US (1) US6528524B2 (es)
EP (1) EP0986390B1 (es)
JP (1) JP2002504109A (es)
CN (1) CN1189174C (es)
AT (1) ATE224716T1 (es)
AU (1) AU740642B2 (es)
CA (1) CA2295704A1 (es)
DE (1) DE69808287T2 (es)
DK (1) DK0986390T3 (es)
ES (1) ES2184285T3 (es)
FR (1) FR2764509A1 (es)
IL (2) IL133222A0 (es)
PT (1) PT986390E (es)
WO (1) WO1998056383A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3104859A1 (en) * 2014-02-12 2016-12-21 Adam Mickiewicz University Application of cinchona alkaloid derivatives as cytotoxic compounds
US11066421B1 (en) 2021-02-09 2021-07-20 Ares Pharmaceuticals, LLC Synthetic cinchona alkaloids against cancer
US11649232B2 (en) 2021-05-10 2023-05-16 Ares Pharmaceuticals, LLC Synthetic dimeric cinchona alkaloids against cancer

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0052608A1 (en) 1980-05-27 1982-06-02 ROSE, Calvin D. Drum pitch modulation
CA2081343C (fr) * 1991-02-25 2003-09-16 Bruno Chauffert Agents therapeutiques pour le traitement de la resistance multi-drogue dans les cas de cancer
NZ247516A (en) * 1993-04-28 1995-02-24 Bernard Charles Sherman Water dispersible pharmaceutical compositions comprising drug dissolved in solvent system comprising at least one alcohol and at least one surfactant

Also Published As

Publication number Publication date
EP0986390B1 (fr) 2002-09-25
DE69808287T2 (de) 2003-06-26
AU740642B2 (en) 2001-11-08
WO1998056383A1 (fr) 1998-12-17
PT986390E (pt) 2003-01-31
CN1259869A (zh) 2000-07-12
CA2295704A1 (fr) 1998-12-17
US20020091136A1 (en) 2002-07-11
IL133222A (en) 2006-08-01
FR2764509A1 (fr) 1998-12-18
US6528524B2 (en) 2003-03-04
JP2002504109A (ja) 2002-02-05
DK0986390T3 (da) 2003-01-27
ATE224716T1 (de) 2002-10-15
AU7924498A (en) 1998-12-30
IL133222A0 (en) 2001-03-19
CN1189174C (zh) 2005-02-16
DE69808287D1 (de) 2002-10-31
EP0986390A1 (fr) 2000-03-22

Similar Documents

Publication Publication Date Title
IL97025A0 (en) 17beta-substituted-4-aza-5alpha-androstan-3-one derivatives,their preparation and pharmaceutical compositions containing them
BG104315A (en) Prostaglandine agonists and their application for the treatment of osteal diseases
ES2191048T3 (es) Derivados de oxazolidinona y compuestos farmaceuticos que los contienen.
PL262105A1 (en) The method of manufacture of new derivatives of benzimidazole
MY115339A (en) Compositions containing micronized nebivolol
UA32543C2 (uk) Арилацетаміди, що мають анальгетичну дію, спосіб їх одержання, фармацевтична композиція та спосіб її одержання
UA27749C2 (uk) Заміщені циклопропіламіно-1,3,5-триазини, їх оптичні ізомери, рацемічні суміші чи їх солі приєднання нетоксичних фармацевтично прийнятних кислот, що мають фармакологічну активність, спосіб їх одержання (варіанти) та фармацевтична композиція на їх основі
ZA968956B (en) Substituted 2,4-imidazolidinedione compounds as pharmaceutical active ingredients
MX9605741A (es) Clorhidrato cristalino del (r)-(-)-2-{n-[4-(1,1-dioxido-3-oxo-2,3-dihidro-benzisotiazol-2-il)-butil ]-aminometil} cromano.
HU9501623D0 (en) Use of 2-amino-6-a-propylamino-4,5,6,7-tetrahydrobenzothiazole (pramipexol) as an antidepressant drug
SE8404065D0 (sv) Novel biologically active compounds
MX9708394A (es) Composicion farmaceutica que contiene clorhidrato de tiagabina y el proceso para su preparacion.
PL350568A1 (en) N-(2-phenyl-4-aminobutyl)-1-naphtamides as antagonists of neurokinin 1 receptors
HU895241D0 (en) Process for the preparation of substituted 1,3,5-triazin-trione derivatives and pharmaceutical compositions containing said compounds as active ingredient
NZ332545A (es)
ES2184285T3 (es) Compuestos farmaceuticos que contienen diclorhidrato de cinconina.
SE9403137D0 (sv) Derivatives of carbohydrates and compositions containing them
FI923751A (fi) Hexahydrobenso/f/kinolinoner
GEP20032975B (en) Echinocandin Derivatives, Preparation Method and Pharmaceutical Composition
ES2065855A1 (es) Procedimiento para la preparacion de nuevos derivados desoxiazafosfolipidicos con accion inhibidora de la fosfolipasa a2, nuevos derivados desoxiazafosfolipidicos obtenidos y utilizacion de los mismos.
UA32583C2 (uk) Похідні арилтіоалкілтіопіридину
ES2062214T3 (es) Derivados de aminooligohidroxi inhibidores de renina.
DE60029946D1 (de) Arzneimittel gegen glomerulosclerose
DK0950053T3 (da) Hidtil ukendte benzoylalkyl.1,2,3,6-tetrahydropyridinderivater
IL106934A (en) Heteroarenylpiperazines a process for their preparation and pharmaceutical compositions comprising them